Cargando…

Endometrial cancer: molecular classification and future treatments

The treatment for endometrial cancer is rapidly evolving with the development of molecular analysis and novel strategies. Surgical resection, cytotoxic chemotherapy, endocrine or hormonal treatment, and radiation have been the staples of treatment for decades. However, precision based approaches for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corr, Bradley, Cosgrove, Casey, Spinosa, Daniel, Guntupalli, Saketh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978763/ https://www.ncbi.nlm.nih.gov/pubmed/36936577 http://dx.doi.org/10.1136/bmjmed-2022-000152

Ejemplares similares

Molecular Classification to Prognosticate Response in Medically Managed Endometrial Cancers and Endometrial Intraepithelial Neoplasia
por: Puechl, Allison M., et al.
Publicado: (2021)

Lymphovascular Space Invasion in Robotic Surgery for Endometrial Cancer
por: Hopkins, Mark R., et al.
Publicado: (2014)

The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment Decisions
por: Alexa, Matthias, et al.
Publicado: (2021)

Fertility Sparing Treatments in Endometrial Cancer Patients: The Potential Role of the New Molecular Classification
por: Cavaliere, Anna Franca, et al.
Publicado: (2021)

Molecular Basis of Endometriosis and Endometrial Cancer: Current Knowledge and Future Perspectives
por: Terzic, Milan, et al.
Publicado: (2021)

Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification
por: Kasius, Jenneke C., et al.
Publicado: (2021)

A Modern Approach to Endometrial Carcinoma: Will Molecular Classification Improve Precision Medicine in the Future?
por: Marnitz, Simone, et al.
Publicado: (2020)

Retrospective Analysis of Survival Improvement by Molecular Biomarker-Based Personalized Chemotherapy for Recurrent Ovarian Cancer
por: Kim, Youngchul, et al.
Publicado: (2014)

Upgrading Treatment and Molecular Diagnosis in Endometrial Cancer—Driving New Tools for Endometrial Preservation?
por: Dellino, Miriam, et al.
Publicado: (2023)

Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy
por: van den Heerik, Anne Sophie V M, et al.
Publicado: (2021)

Fertility Preservation in Endometrial Cancer—Treatment and Molecular Aspects
por: Schubert, Melanie, et al.
Publicado: (2023)

A complete durable response of vaginal clear cell carcinoma with pembrolizumab: A case report
por: Porragas-Paseiro, Hector S., et al.
Publicado: (2023)

Molecular classification of endometrial cancer: entering an era of precision medicine
por: Goulder, Alison, et al.
Publicado: (2022)

A clinically applicable molecular-based classification for endometrial cancers
por: Talhouk, A, et al.
Publicado: (2015)

Modeling Endometrial Cancer: Past, Present, and Future
por: Van Nyen, Tom, et al.
Publicado: (2018)

Utilizing preoperative arterial embolization to minimize blood loss at time of vulvar sarcoma resection: A case report
por: Schulte, Vera, et al.
Publicado: (2022)

Cotyledonoid dissecting leiomyoma with adipocytic differentiation: A case report()
por: Blake, Erin A., et al.
Publicado: (2014)

The importance of molecular classification of endometrial carcinomas in clinical practice: how to apply it and difficulties in application
por: Enneli, Duygu
Publicado: (2023)

Clinical presentation of brain metastases from endometrial carcinoma: A case series
por: Moroney, Marisa R., et al.
Publicado: (2019)

TCGA Molecular Prognostic Groups of Endometrial Carcinoma: Current Knowledge and Future Perspectives
por: Arciuolo, Damiano, et al.
Publicado: (2022)

Fertility-sparing treatment in early endometrial cancer: current state and future strategies
por: Obermair, Andreas, et al.
Publicado: (2020)

What’s New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives
por: Tirino, Giuseppe, et al.
Publicado: (2018)

The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer
por: Jamieson, Amy, et al.
Publicado: (2021)

The Advance and Correlation of KRAS Mutation With the Fertility-Preservation Treatment of Endometrial Cancer in the Background of Molecular Classification Application
por: Yu, KeXuan, et al.
Publicado: (2021)

Outcomes of fertility preservation treatments in patients with endometrial cancer with different molecular classifications based on an NGS panel
por: Xu, Yan, et al.
Publicado: (2023)

Fertility-Sparing Approaches in Atypical Endometrial Hyperplasia and Endometrial Cancer Patients: Current Evidence and Future Directions
por: Contreras, Nayanar-Adela, et al.
Publicado: (2022)

The prognosis of endometrial cancers stratified with conventional risk factors and modified molecular classification
por: Yamazaki, Hiroyuki, et al.
Publicado: (2022)

A new strategy in molecular typing: the accuracy of an NGS panel for the molecular classification of endometrial cancers
por: Li, Yang, et al.
Publicado: (2022)

Past, present, and future of hormonal therapy in recurrent endometrial cancer
por: Carlson, Matthew J, et al.
Publicado: (2014)

New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care
por: Talhouk, A., et al.
Publicado: (2016)

Preparedness of Ob/Gyn residents for fellowship training in gynecologic oncology
por: Doo, David W., et al.
Publicado: (2015)

Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm: A Randomized Clinical Trial
por: Guntupalli, Saketh R., et al.
Publicado: (2020)

Incorporation of molecular characteristics into endometrial cancer management
por: Vermij, Lisa, et al.
Publicado: (2019)

Molecular Classification of Endometrial Carcinoma: Protocol for a Cohort Study
por: Moreira, Inês, et al.
Publicado: (2022)

Metabolism-associated molecular classification of uterine corpus endometrial carcinoma
por: Zhao, Munan, et al.
Publicado: (2023)

The role of TCGA molecular classification in clear cell endometrial carcinoma
por: Tang, Xinyue, et al.
Publicado: (2023)

Molecular Classification of Endometrial Cancer and the 2023 FIGO Staging: Exploring the Challenges and Opportunities for Pathologists
por: Zheng, Wenxin
Publicado: (2023)

Role of Genomic and Molecular Biology in the Modulation of the Treatment of Endometrial Cancer: Narrative Review and Perspectives
por: Cuccu, Ilaria, et al.
Publicado: (2023)

The perceptions of gynecologic oncology fellows on readiness for subspecialty training following OB/GYNRESIDENCY
por: Urban, Renata R., et al.
Publicado: (2019)

Pre-treatment Risk Assessment of Women with Endometrial Cancer: Differences in Outcomes of Molecular and Clinical Classifications in The Slovenian Patient Cohort
por: Knez, Jure, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dpas4j1i3avr5u251siedjh2k6